Brief: Hofseth Biocare Q2 EBITDA Loss Narrows To NOK 8.4 Million
Aug 30 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Q2 SALES REVENUE NOK 12.8 MILLION VERSUS NOK 14.6 MILLION YEAR AGO
* Q2 EBITDA LOSS NOK 8.4 MILLION VERSUS LOSS NOK 12.9 MILLION YEAR AGO
Source text for Eikon: ID:nGNE9pKTPr
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering